“Medicine Without Blood,” 3-part series in New Yorker on ways Jehovah’s Witnesses have changed how doctors think about blood transfusion: [Note: You get 6 free articles, so be careful if you also access their cartoons via Twitter.)
Abbott challenged the only known gay juror for a trial in which SKB challenged Abbott's controversial 400% price increase for an HIV medication [SKB is now GlaxoSmithKline, GSK]
The panel held that, because of the history of excluding gays and lesbians from democratic institutions and the pervasiveness of stereotypes about the group, that equal protection forbids striking a juror on the basis of sexual orientation AND remanded the case for a new trial.
Spokesperson quote: Chinese scientists have invented a Nucleic Acid Testing (NAT) technique that could shorten the window period from the current 20 days to 10 days, and we will promote the test to cover all nationwide blood collecting centers this year.
Lab tech tested blood as 'A positive' instead of 'O positive', but with no 'A pos' blood, tech labelled bag of 'O pos' as 'A pos' and sent it to hospital. During transfusion, a relative said patient was 'O pos.'
Judgment in respect of urgent application by NHS Trust to treat young boy with severe burns whose skin grafts might require a blood transfusion; Jehovah's Witness parents had refused consent to transfusion. Application granted.
Usual medical practice is ABCDE – airway, breathing, circulation, disability, exposure, but in Afghanistan it was 'control of catastrophic haemorrhage'. If you've got both legs and an arm missing, you'll dump your blood volume into dirt long before an airway problem kills you.
5 big players: USA's Baxter and Talecris, Australia's CSL, Spain's Grifols, Switzerland's Octapharma, possibly Biotest AG, an arm of the Dutch nonprofit Sanquin. Since 2008, plasma pharmaceuticals have increased from $4b to more than $11b
Action follows (1) lawsuit alleging it gave kickbacks to physicians to order unnecessary blood tests and to send blood samples to HDL when less expensive clinical labs were qualified; (2) Agreeing to $100 million fine to settle charges with federal investigators; (3) Filing for bankruptcy protection
Immucor's PreciseType test costs ~$350 USD. Prices charged to patients are established by hospitals and insurance companies. Immucor says it is currently in discussions with insurance companies on reimbursement levels.
PHSA improves the health of British Columbians by seeking province-wide solutions to specialized health care needs in collaboration with BC health authorities and other partners. For more information, visit www.phsa.ca